Back to news

Elanco Animal Health Slides as Analyst Downgrade Pressures Shares

Investivoq PriceTracker

Elanco Animal Health (ELAN) is down 3.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is an analyst downgrade that hit the stock before the open and reset expectations for the animal health group. The move appears tied less to a company-specific operational setback today and more to fresh concerns that pricing power across the sector may weaken, which can matter for a company expected to rely heavily on execution and margin improvement.

Details:

  • Jefferies downgraded ELAN to Hold from Buy and cut its price target to $24 from $31, a notable reset in expected upside.
  • The downgrade was tied to rising concern about pricing risk in animal health, with the view that sector pricing may become harder to sustain.
  • Elanco has recently emphasized volume growth, market-share gains, and momentum from newer products, so a market shift toward lower pricing confidence could weigh on how investors value that progress.
  • Recent company materials had pointed to improved 2026 execution and stronger innovation momentum, which may have made the negative rating change stand out more sharply against an otherwise improving narrative.

    • Sources:

    Elanco Investor Relations, Investing.com, MarketScreener

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ELAN Insider Trading Activity

    ELAN Insider Trades

    $ELAN insiders have traded $ELAN stock on the open market 7 times in the past 6 months. Of those trades, 6 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $ELAN stock by insiders over the last 6 months:

    • LAWRENCE ERIK KURZIUS purchased 40,000 shares for an estimated $935,920
    • PAUL HERENDEEN purchased 10,000 shares for an estimated $236,850
    • MICHAEL J HARRINGTON purchased 5,000 shares for an estimated $109,100
    • TIMOTHY J BETTINGTON (SEE REMARKS) sold 4,350 shares for an estimated $100,050
    • RAJEEV A. MODI (SEE REMARKS) purchased 4,911 shares for an estimated $99,938
    • JEFFREY N SIMMONS (PRESIDENT, CEO AND DIRECTOR) purchased 4,971 shares for an estimated $99,842
    • ROBERT M VANHIMBERGEN (EVP and CFO) purchased 4,200 shares for an estimated $96,925

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive ELAN Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $ELAN Hedge Fund Activity

    We have seen 245 institutional investors add shares of $ELAN stock to their portfolio, and 263 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 12,014,054 shares (+71.8%) to their portfolio in Q2 2026, for an estimated $295,665,868
    • FMR LLC added 6,023,453 shares (+11.8%) to their portfolio in Q2 2026, for an estimated $148,237,178
    • BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 3,581,778 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $88,147,556
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 3,553,213 shares (+inf%) to their portfolio in Q2 2026, for an estimated $87,444,571
    • MARSHALL WACE, LLP added 3,049,938 shares (+220.6%) to their portfolio in Q2 2026, for an estimated $75,058,974
    • INVESCO LTD. removed 2,834,846 shares (-34.8%) from their portfolio in Q2 2026, for an estimated $69,765,560
    • BLACK CREEK INVESTMENT MANAGEMENT INC. added 2,552,571 shares (+24.3%) to their portfolio in Q2 2026, for an estimated $62,818,772

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $ELAN Analyst Ratings

    Wall Street analysts have issued reports on $ELAN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • JP Morgan issued a "Overweight" rating on 05/07/2026

    To track analyst ratings and price targets for $ELAN, check out Investivoq's $ELAN forecast page.

    $ELAN Price Targets

    Multiple analysts have issued price targets for $ELAN recently. We have seen 3 analysts offer price targets for $ELAN in the last 6 months, with a median target of $31.0.

    Here are some recent targets:

    • Steve Scala from TD Cowen set a target price of $32.0 on 06/18/2026
    • Chris Schott from JP Morgan set a target price of $30.0 on 05/07/2026
    • Daniel Grosslight from Citigroup set a target price of $31.0 on 05/07/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.